In the fourth century B.C, Plato wrote that light emanated from the eye, seizing objects in its ray, which allowed us to see them. Centuries later, our understanding of ocular anatomy and physiology has drastically improved. In addition, what was once perceived by humans of antiquity as a punishment from the gods, is today perceived as what it truly is: pathological processes that stem at the molecular level, and manifest all the way up to the systemic level.

Ophthalmic diseases have the potential to take away what many agree is the most important and valued of the 5 senses. Our vision.

At PharmaLegacy, we have a vision. A vision of a world where ophthalmic diseases are history, just like Plato’s extramission theory. With your pipelines, our expertise, and a wide selection of models with immediate availability, we believe that our vision might one day come true. Let’s start your study today.

Contact Us

Top Pharmaceutical Companies Trust PharmaLegacy For Their Preclinical Ophthalmology Studies

Your preclinical ophthalmology studies call for flawless and affordable ophthalmology models. Download our Ophthalmology brochure and see how our models and decades of expertise can give you the clarity you need in your pipeline.


    The capability to succeed:

    • AAALAC accredited vivarium
    • Research data electronically managed by BioBook (IDBS, UK)
    • 1000+ validated, in-stock animal models spanning 40+ indications
    • PK/PD, molecular pharmacology and preliminary toxicology adjacency studies
    quality section

    Work with a CRO that sees past the horizon. Work with PharmaLegacy.